Clinical Trials
3 trialsNCT05890781 2026-02-09
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT02864563 2023-12-01
PHRCNB07
Institut Curie
Phase NA Completed
NCT03860207 2023-09-13
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
Y-mAbs Therapeutics
Phase 1/2 Terminated